Skip to main content
SpringerLink
Log in

P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells

  • Review
  • Published:
Purinergic Signalling Aims and scope Submit manuscript

Abstract

The P2Y12 receptor is a Gi-coupled ADP receptor first described in blood platelets where it plays a central role in the complex processes of activation and aggregation. Platelet granules store important amounts of ADP which are released upon stimulation by interaction of platelets with the damaged vessel wall. Therefore, the P2Y12 receptor is a key player in primary hemostasis and in arterial thrombosis and is an established target of antithrombotic drugs like the thienopyridine compounds ticlopidine, clopidogrel, and prasugrel or the direct, reversible antagonists ticagrelor and cangrelor. Beyond the platelet physiology and pharmacology, recent studies have revealed the expression of the P2Y12 receptor in other hematopoietic cells including leukocyte subtypes and microglia in the central nervous system as well as in vascular smooth muscle cells. These studies indicate putative roles of the P2Y12 receptor in inflammatory states and diseases of the brain, lung, and blood vessels. The selective role of P2Y12 among other P2 receptors as well as the possible impact of P2Y12 targeting drugs in these processes remain to be evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817):202–207

    Article  PubMed  CAS  Google Scholar 

  2. Zhang FL, Luo L, Gustafson E, Lachowicz J, Smith M, Qiao X, Liu YH, Chen G, Pramanik B, Laz TM, Palmer K, Bayne M, Monsma FJ Jr (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276(11):8608–8615

    Article  PubMed  CAS  Google Scholar 

  3. Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ Jr, Wiekowski MT, Abbondanzo SJ, Cook DN, Bayne ML, Lira SA, Chintala MS (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107(12):1591–1598

    Article  PubMed  CAS  Google Scholar 

  4. Savi P, Labouret C, Delesque N, Guette F, Lupker J, Herbert JM (2001) P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 283(2):379–383

    Article  PubMed  CAS  Google Scholar 

  5. Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, Soga T, Matsushime H, Furuichi K (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 60(3):432–439

    PubMed  CAS  Google Scholar 

  6. Gachet C (2001) ADP receptors of platelets and their inhibition. Thromb Haemost 86(1):222–232

    PubMed  CAS  Google Scholar 

  7. Gachet C, Hechler B, Leon C, Vial C, Leray C, Ohlmann P, Cazenave JP (1997) Activation of ADP receptors and platelet function. Thromb Haemost 78(1):271–275

    PubMed  CAS  Google Scholar 

  8. Gachet C, Hechler B, Leon C, Vial C, Ohlmann P, Cazenave JP (1996) Purinergic receptors on blood platelets. Platelets 7(5–6):261–267. doi:10.3109/09537109609023587

    Article  PubMed  CAS  Google Scholar 

  9. von Kugelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110(3):415–432. doi:10.1016/j.pharmthera.2005.08.014

    Article  CAS  Google Scholar 

  10. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341

    Article  PubMed  CAS  Google Scholar 

  11. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12):1512–1519. doi:10.1038/nn1805

    Article  PubMed  CAS  Google Scholar 

  12. Hogberg C, Svensson H, Gustafsson R, Eyjolfsson A, Erlinge D (2010) The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. Int J Cardiol 142(2):187–192. doi:10.1016/j.ijcard.2008.12.091

    Article  PubMed  Google Scholar 

  13. Wihlborg AK, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T, Erlinge D (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10):1810–1815

    Article  PubMed  CAS  Google Scholar 

  14. Ben Addi A, Cammarata D, Conley PB, Boeynaems JM, Robaye B (2010) Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 185(10):5900–5906. doi:10.4049/jimmunol.0901799

    Article  PubMed  CAS  Google Scholar 

  15. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, Robaye B, Conley PB, Kim HC, Sargin S, Schon P, Schwab A, Hanley PJ (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3(132):ra55. doi:10.1126/scisignal.2000588

    Article  PubMed  CAS  Google Scholar 

  16. Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M (2010) Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes. Basic Res Cardiol 105(3):379–387. doi:10.1007/s00395-009-0073-8

    Article  PubMed  CAS  Google Scholar 

  17. Garcia AE, Mada SR, Rico MC, Dela Cadena RA, Kunapuli SP (2011) Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis. PLoS One 6(10):e26035. doi:10.1371/journal.pone.0026035

    Article  PubMed  CAS  Google Scholar 

  18. Gachet C, Hechler B (2005) The platelet P2 receptors in thrombosis. Semin Thromb Hemost 31(2):162–167. doi:10.1055/s-2005-869521

    Article  PubMed  CAS  Google Scholar 

  19. Kauffenstein G, Hechler B, Cazenave JP, Gachet C (2004) Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor. J Thromb Haemost 2(11):1980–1988

    Article  PubMed  CAS  Google Scholar 

  20. Savi P, Zachayus JL, Delesque-Touchard N, Labouret C, Herve C, Uzabiaga MF, Pereillo JM, Culouscou JM, Bono F, Ferrara P, Herbert JM (2006) The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A 103(29):11069–11074

    Article  PubMed  CAS  Google Scholar 

  21. Algaier I, Jakubowski JA, Asai F, von Kugelgen I (2008) Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor. J Thromb Haemostasis 6(11):1908–1914. doi:10.1111/j.1538-7836.2008.03136.x

    Article  CAS  Google Scholar 

  22. Cattaneo M (2010) New P2Y(12) inhibitors. Circulation 121(1):171–179. doi:10.1161/CIRCULATIONAHA.109.853069

    Article  PubMed  Google Scholar 

  23. Van Giezen J, Nilsson L, Berntsson P, Wissing BM, Giordanetto F, Tomlinson W, Greasley PJ (2009) Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. J Thromb Haemostasis 7(9):1556–1565. doi:10.1111/j.1538-7836.2009.03527.x

    Article  CAS  Google Scholar 

  24. Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451(7181):914–918

    Article  PubMed  CAS  Google Scholar 

  25. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327(5965):580–583. doi:10.1126/science.1181928

    Article  PubMed  CAS  Google Scholar 

  26. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378–3384

    Article  PubMed  CAS  Google Scholar 

  27. Jain S, Harris J, Ware J (2010) Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 30(12):2362–2367. doi:10.1161/ATVBAHA.110.207514

    Article  PubMed  CAS  Google Scholar 

  28. O'Sullivan BP, Linden MD, Frelinger AL 3rd, Barnard MR, Spencer-Manzon M, Morris JE, Salem RO, Laposata M, Michelson AD (2005) Platelet activation in cystic fibrosis. Blood 105(12):4635–4641. doi:10.1182/blood-2004-06-2098

    Article  PubMed  CAS  Google Scholar 

  29. Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180(93):1332–1339

    Article  PubMed  CAS  Google Scholar 

  30. Born GV (1985) Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. Circulation 72(4):741–746

    Article  PubMed  CAS  Google Scholar 

  31. Jones S, Evans RJ, Mahaut-Smith MP (2011) Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation. Br J Haematol 153(1):83–91. doi:10.1111/j.1365-2141.2010.08499.x

    Article  PubMed  CAS  Google Scholar 

  32. Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA (1975) Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 228(6):1757–1765

    PubMed  CAS  Google Scholar 

  33. Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277–300

    Article  PubMed  CAS  Google Scholar 

  34. Hechler B, Gachet C (2011) P2 receptors and platelet function. Purinergic Signal 7(3):293–303. doi:10.1007/s11302-011-9247-6

    Article  PubMed  CAS  Google Scholar 

  35. Baurand A, Raboisson P, Freund M, Léon C, Cazenave JP, Bourguignon JJ, Gachet C (2001) Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 412(3):213–221

    Article  PubMed  CAS  Google Scholar 

  36. Ohlmann P, de Castro S, Brown GG Jr, Gachet C, Jacobson KA, Harden TK (2010) Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate ([(125)I]MRS2500). Pharmacol Res 62(4):344–351. doi:10.1016/j.phrs.2010.05.007

    Article  PubMed  CAS  Google Scholar 

  37. Hechler B, Leon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C (1998) The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 92(1):152–159

    PubMed  CAS  Google Scholar 

  38. Jin J, Daniel JL, Kunapuli SP (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273(4):2030–2034

    Article  PubMed  CAS  Google Scholar 

  39. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, Herbert JM (1998) Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 422(3):291–295

    Article  PubMed  CAS  Google Scholar 

  40. Léon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104(12):1731–1737

    Article  PubMed  Google Scholar 

  41. Mangin P, Ohlmann P, Eckly A, Cazenave JP, Lanza F, Gachet C (2004) The P2Y receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented. J Thromb Haemost 2(6):969–977

    Article  PubMed  CAS  Google Scholar 

  42. Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C (1998) The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 103(3):858–866

    Article  PubMed  CAS  Google Scholar 

  43. Dorsam RT, Kim S, Jin J, Kunapuli SP (2002) Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. J Biol Chem 277(49):47588–47595

    Article  PubMed  CAS  Google Scholar 

  44. Nieswandt B, Schulte V, Zywietz A, Gratacap MP, Offermanns S (2002) Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. J Biol Chem 277(42):39493–39498

    Article  PubMed  CAS  Google Scholar 

  45. Gratacap MP, Herault JP, Viala C, Ragab A, Savi P, Herbert JM, Chap H, Plantavid M, Payrastre B (2000) FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Blood 96(10):3439–3446

    PubMed  CAS  Google Scholar 

  46. Polgar J, Eichler P, Greinacher A, Clemetson KJ (1998) Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 91(2):549–554

    PubMed  CAS  Google Scholar 

  47. Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave JP, Zirngibl H, Offermanns S, Gachet C (2001) Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood 97(12):3829–3835

    Article  PubMed  CAS  Google Scholar 

  48. Ohlmann P, Eckly A, Freund M, Cazenave JP, Offermanns S, Gachet C (2000) ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood 96(6):2134–2139

    PubMed  CAS  Google Scholar 

  49. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML (2000) Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet ‘primary secretion defect’ are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 20(11):E101–E106

    Article  PubMed  CAS  Google Scholar 

  50. Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM (1997) Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost 77(5):986–990

    PubMed  CAS  Google Scholar 

  51. Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF (1990) Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 75(5):1081–1086

    PubMed  CAS  Google Scholar 

  52. Humbert M, Nurden P, Bihour C, Pasquet JM, Winckler J, Heilmann E, Savi P, Herbert JM, Kunicki TJ, Nurden AT (1996) Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol 16(12):1532–1543

    Article  PubMed  CAS  Google Scholar 

  53. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson EA, Cazenave JP, Chap H, Gachet C (1999) A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94(12):4156–4165

    PubMed  CAS  Google Scholar 

  54. Eckly A, Gendrault JL, Hechler B, Cazenave JP, Gachet C (2001) Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 85(4):694–701

    PubMed  CAS  Google Scholar 

  55. Cattaneo M (2011) The platelet P2Y receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 117(7):2102–2112. doi:10.1182/blood-2010-08-263111

    Article  PubMed  CAS  Google Scholar 

  56. Cattaneo M (2011) Molecular defects of the platelet P2 receptors. Purinergic Signal 7(3):333–339

    Article  PubMed  CAS  Google Scholar 

  57. El-Tayeb A, Griessmeier KJ, Muller CE (2005) Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors. Bioorg Med Chem Lett 15(24):5450–5452. doi:10.1016/j.bmcl.2005.08.104

    Article  PubMed  CAS  Google Scholar 

  58. Ohlmann P, Lecchi A, El Tayeb A, Muller C, Cattaneo M, Gachet C The new selective P2Y12 antagonist radioligand [3H]PSB-0413 is a highly accurate tool to quantify the platelet P2Y12 receptors under both normal and pathological conditions [P-TH-028]. In: XXIIIrd Congress of International Society on Thrombosis and Haemostasis, Kyoto, Japan, 2011

  59. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P (2009) Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 16(9):961–966. doi:10.1038/nsmb.1651

    Article  PubMed  CAS  Google Scholar 

  60. Jin J, Kunapuli SP (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 95(14):8070–8074

    Article  PubMed  CAS  Google Scholar 

  61. Léon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, Spannagl M, Gachet C, Engelmann B (2004) Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103(2):594–600

    Article  PubMed  CAS  Google Scholar 

  62. Léon C, Ravanat C, Freund M, Cazenave JP, Gachet C (2003) Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 23(10):1941–1947

    Article  PubMed  CAS  Google Scholar 

  63. Léon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C (2001) Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 103(5):718–723

    PubMed  Google Scholar 

  64. Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S (2000) The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 110(4):925–934

    Article  PubMed  CAS  Google Scholar 

  65. Kotova YN, Ataullakhanov FI, Panteleev MA (2008) Formation of coated platelets is regulated by the dense granule secretion of adenosine 5′diphosphate acting via the P2Y12 receptor. J Thromb Haemost 6(9):1603–1605. doi:10.1111/j.1538-7836.2008.03052.x

    Article  PubMed  CAS  Google Scholar 

  66. van der Meijden PE, Feijge MA, Giesen PL, Huijberts M, van Raak LP, Heemskerk JW (2005) Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost 93(6):1128–1136. doi:10.1267/THRO05061128

    PubMed  Google Scholar 

  67. Jantzen HM, Milstone DS, Gousset L, Conley PB, Mortensen RM (2001) Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest 108(3):477–483

    PubMed  CAS  Google Scholar 

  68. Ohlmann P, Laugwitz KL, Nurnberg B, Spicher K, Schultz G, Cazenave JP, Gachet C (1995) The human platelet ADP receptor activates Gi2 proteins. Biochem J 312(Pt 3):775–779

    PubMed  CAS  Google Scholar 

  69. Daniel JL, Dangelmaier C, Jin J, Kim YB, Kunapuli SP (1999) Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 82(4):1322–1326

    PubMed  CAS  Google Scholar 

  70. Haslam RJ (1973) Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. Ser Haematol 6(3):333–350

    PubMed  CAS  Google Scholar 

  71. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW (2006) Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 108(9):3045–3052. doi:10.1182/blood-2006-03-006338

    Article  PubMed  CAS  Google Scholar 

  72. Gratacap MP, Guillermet-Guibert J, Martin V, Chicanne G, Tronchere H, Gaits-Iacovoni F, Payrastre B (2011) Regulation and roles of PI3Kbeta, a major actor in platelet signaling and functions. Adv Enzyme Regul 51(1):106–116. doi:10.1016/j.advenzreg.2010.09.011

    Article  PubMed  CAS  Google Scholar 

  73. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH (2005) PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 11(6):507–514

    Article  PubMed  CAS  Google Scholar 

  74. Lova P, Paganini S, Hirsch E, Barberis L, Wymann M, Sinigaglia F, Balduini C, Torti M (2003) A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem 278(1):131–138

    Article  PubMed  CAS  Google Scholar 

  75. Lova P, Paganini S, Sinigaglia F, Balduini C, Torti M (2002) A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 277(14):12009–12015

    Article  PubMed  CAS  Google Scholar 

  76. Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP (2010) Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 115(10):2008–2013. doi:10.1182/blood-2009-04-217224

    Article  PubMed  CAS  Google Scholar 

  77. Canobbio I, Stefanini L, Cipolla L, Ciraolo E, Gruppi C, Balduini C, Hirsch E, Torti M (2009) Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood 114(10):2193–2196. doi:10.1182/blood-2009-03-208074

    Article  PubMed  CAS  Google Scholar 

  78. Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15(11):2019–2021

    PubMed  CAS  Google Scholar 

  79. Li Z, Zhang G, Le Breton GC, Gao X, Malik AB, Du X (2003) Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 278(33):30725–30731

    Article  PubMed  CAS  Google Scholar 

  80. Geiger J, Brich J, Honig-Liedl P, Eigenthaler M, Schanzenbacher P, Herbert JM, Walter U (1999) Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 19(8):2007–2011

    Article  PubMed  CAS  Google Scholar 

  81. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C (2005) Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3(1):85–92

    Article  PubMed  CAS  Google Scholar 

  82. Guidetti GF, Lova P, Bernardi B, Campus F, Baldanzi G, Graziani A, Balduini C, Torti M (2008) The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets. J Biol Chem 283(43):28795–28805. doi:10.1074/jbc.M801588200

    Article  PubMed  CAS  Google Scholar 

  83. Stefanini L, Bergmeier W (2010) CalDAG-GEFI and platelet activation. Platelets 21(4):239–243. doi:10.3109/09537101003639931

    Article  PubMed  CAS  Google Scholar 

  84. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, Gachet C (2000) Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84(3):484–491

    PubMed  CAS  Google Scholar 

  85. Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, Leon C, Gachet C (2005) Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties? Mol Pharmacol 67(3):721–733. doi:10.1124/mol.104.004846

    Article  PubMed  CAS  Google Scholar 

  86. Fam SR, Gallagher CJ, Kalia LV, Salter MW (2003) Differential frequency dependence of P2Y1- and P2Y2- mediated Ca 2+ signaling in astrocytes. J Neurosci 23(11):4437–4444

    PubMed  CAS  Google Scholar 

  87. Hoffmann C, Ziegler N, Reiner S, Krasel C, Lohse MJ (2008) Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J Biol Chem 283(45):30933–30941. doi:10.1074/jbc.M801472200

    Article  PubMed  CAS  Google Scholar 

  88. Mundell SJ, Jones ML, Hardy AR, Barton JF, Beaucourt SM, Conley PB, Poole AW (2006) Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function. Mol Pharmacol 70(3):1132–1142. doi:10.1124/mol.106.023549

    Article  PubMed  CAS  Google Scholar 

  89. Reiner S, Ziegler N, Leon C, Lorenz K, von Hayn K, Gachet C, Lohse MJ, Hoffmann C (2009) beta-Arrestin-2 interaction and internalization of the human P2Y1 receptor are dependent on C-terminal phosphorylation sites. Mol Pharmacol 76(6):1162–1171. doi:10.1124/mol.109.060467

    Article  PubMed  CAS  Google Scholar 

  90. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105(9):3552–3560. doi:10.1182/blood-2004-07-2893

    Article  PubMed  CAS  Google Scholar 

  91. Li D, D'Angelo L, Chavez M, Woulfe DS (2011) Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. J Biol Chem 286(5):3805–3814. doi:10.1074/jbc.M110.118018

    Article  PubMed  CAS  Google Scholar 

  92. Schaff M, Receveur N, Bourdon C, Lanza F, Gachet C, Mangin P (2011) Beta-arrestin-1 participates in thrombosis and regulates integrin alphaIIbbeta3 signalling without affecting P2Y receptors desensitization and function. Thromb Haemost under revision

  93. Nisar S, Daly ME, Federici AB, Artoni A, Mumford AD, Watson SP, Mundell SJ (2011) An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets. Blood 118(20):5641–5651. doi:10.1182/blood-2011-02-336826

    Article  PubMed  CAS  Google Scholar 

  94. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108(8):989–995

    Article  PubMed  CAS  Google Scholar 

  95. Staritz P, Kurz K, Stoll M, Giannitsis E, Katus HA, Ivandic BT (2009) Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. Int J Cardiol 133(3):341–345. doi:10.1016/j.ijcard.2007.12.118

    Article  PubMed  Google Scholar 

  96. Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease: a case–control study. Circulation 108(24):2971–2973

    Article  PubMed  Google Scholar 

  97. Cavallari U, Trabetti E, Malerba G, Biscuola M, Girelli D, Olivieri O, Martinelli N, Angiolillo DJ, Corrocher R, Pignatti PF (2007) Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease. BMC Med Genet 8:59. doi:10.1186/1471-2350-8-59

    Article  PubMed  CAS  Google Scholar 

  98. Bura A, Bachelot-Loza C, Ali FD, Aiach M, Gaussem P (2006) Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects. J Thromb Haemost 4(9):2096–2097. doi:10.1111/j.1538-7836.2006.02113.x

    Article  PubMed  CAS  Google Scholar 

  99. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS (2007) Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res 119(3):355–360. doi:10.1016/j.thromres.2006.02.006

    Article  PubMed  CAS  Google Scholar 

  100. Zee RY, Michaud SE, Diehl KA, Chasman DI, Emmerich J, Gaussem P, Aiach M, Ridker PM (2008) Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Atherosclerosis 197(2):694–699. doi:10.1016/j.atherosclerosis.2007.07.001

    Article  PubMed  CAS  Google Scholar 

  101. Zhong X, Kriz R, Seehra J, Kumar R (2004) N-linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression. FEBS Lett 562(1–3):111–117

    Article  PubMed  CAS  Google Scholar 

  102. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM (1992) Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80(11):2787–2796

    PubMed  CAS  Google Scholar 

  103. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb–IIIa complex function. J Clin Invest 95(4):1612–1622

    Article  PubMed  CAS  Google Scholar 

  104. Cattaneo M (2011) Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Haemost 105(Suppl 1):S67–S74. doi:10.1160/THS10-11-0742

    Article  PubMed  CAS  Google Scholar 

  105. Cattaneo M, Zighetti ML, Lombardi R, Martinez C, Lecchi A, Conley PB, Ware J, Ruggeri ZM (2003) Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A 100(4):1978–1983

    Article  PubMed  CAS  Google Scholar 

  106. Daly ME, Dawood BB, Lester WA, Peake IR, Rodeghiero F, Goodeve AC, Makris M, Wilde JT, Mumford AD, Watson SP, Mundell SJ (2009) Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study. Blood 113(17):4110–4113. doi:10.1182/blood-2008-11-190850

    Article  PubMed  CAS  Google Scholar 

  107. Remijn JA, IJsseldijk MJ, Strunk AL, Abbes AP, Engel H, Dikkeschei B, Dompeling EC, de Groot PG, Slingerland RJ (2007) Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis. Clin Chem Lab Med 45(2):187–189. doi:10.1515/CCLM.2007.036

    Article  PubMed  CAS  Google Scholar 

  108. Shiraga M, Miyata S, Kato H, Kashiwagi H, Honda S, Kurata Y, Tomiyama Y, Kanakura Y (2005) Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost 3(10):2315–2323. doi:10.1111/j.1538-7836.2005.01554.x

    Article  PubMed  CAS  Google Scholar 

  109. Savi P, Herbert JM (2005) Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 31(2):174–183

    Article  PubMed  CAS  Google Scholar 

  110. Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM (2000) Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 84(5):891–896

    PubMed  CAS  Google Scholar 

  111. Mills DC, Puri R, Hu CJ, Minniti C, Grana G, Freedman MD, Colman RF, Colman RW (1992) Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb 12(4):430–436

    Article  PubMed  CAS  Google Scholar 

  112. Savi P, Laplace MC, Herbert JM (1994) Evidence for the existence of two different ADP-binding sites on rat platelets. Thromb Res 76(2):157–169

    Article  PubMed  CAS  Google Scholar 

  113. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave JP (1995) Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 91(2):434–444

    Article  PubMed  CAS  Google Scholar 

  114. Quinton TM, Murugappan S, Kim S, Jin J, Kunapuli SP (2004) Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J Thromb Haemost 2(6):978–984

    Article  PubMed  CAS  Google Scholar 

  115. Meadows TA, Bhatt DL (2007) Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 100(9):1261–1275. doi:10.1161/01.RES.0000264509.36234.51

    Article  PubMed  CAS  Google Scholar 

  116. O'Connor S, Montalescot G, Collet J (2011) The P2Y(12) receptor as a target of antithrombotic drugs. Purinergic Signal 7(3):325–332

    Article  PubMed  CAS  Google Scholar 

  117. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015. doi:10.1056/NEJMoa0706482

    Article  PubMed  CAS  Google Scholar 

  118. Bhatt DL (2009) Prasugrel in clinical practice. N Engl J Med 361(10):940–942

    Article  PubMed  CAS  Google Scholar 

  119. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057. doi:10.1056/NEJMoa0904327

    Article  PubMed  CAS  Google Scholar 

  120. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Luscher TF (2007) Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 12(2):113–122

    Article  PubMed  Google Scholar 

  121. Afek A, Kogan E, Maysel-Auslender S, Mor A, Regev E, Rubinstein A, Keren G, George J (2009) Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvasc Res 77(3):364–369. doi:10.1016/j.mvr.2009.01.009

    Article  PubMed  CAS  Google Scholar 

  122. Evans DJ, Jackman LE, Chamberlain J, Crosdale DJ, Judge HM, Jetha K, Norman KE, Francis SE, Storey RF (2009) Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis. Circulation 119(1):116–122. doi:10.1161/CIRCULATIONAHA.107.762690

    Article  PubMed  CAS  Google Scholar 

  123. Li M, Zhang Y, Ren H, Zhu X (2007) Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 194(2):348–356. doi:10.1016/j.atherosclerosis.2006.11.006

    Article  PubMed  CAS  Google Scholar 

  124. Patil SB, Jackman LE, Francis SE, Judge HM, Nylander S, Storey RF (2010) Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima. Arterioscler Thromb Vasc Biol 30(12):2385–2391. doi:10.1161/ATVBAHA.110.210732

    Article  PubMed  CAS  Google Scholar 

  125. Schulz C, Konrad I, Sauer S, Orschiedt L, Koellnberger M, Lorenz R, Walter U, Massberg S (2008) Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Thromb Haemost 99(1):190–195

    PubMed  CAS  Google Scholar 

  126. Abele S, Spriewald BM, Ramsperger-Gleixner M, Wollin M, Hiemann NE, Nieswandt B, Weyand M, Ensminger SM (2009) Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts. Transplantation 87(2):207–216. doi:10.1097/TP.0b013e3181938913

    Article  PubMed  CAS  Google Scholar 

  127. Yashiro K, Matsumoto Y, Ihara H, Suzuki Y, Kondo K, Urano T, Umemura K (2009) Involvement of platelet activation by P2Y12 receptor in the development of transplant arteriosclerosis in mice. Transplantation 87(5):660–667. doi:10.1097/TP.0b013e318196305a

    Article  PubMed  CAS  Google Scholar 

  128. Harada K, Matsumoto Y, Umemura K (2011) Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis. Transplantation 92(2):148–154. doi:10.1097/TP.0b013e318221d407

    Article  PubMed  CAS  Google Scholar 

  129. Gresele P, Grasselli S, Todisco T, Nenci GG (1985) Platelets and asthma. Lancet 1(8424):347

    Article  PubMed  CAS  Google Scholar 

  130. Pitchford SC, Momi S, Giannini S, Casali L, Spina D, Page CP, Gresele P (2005) Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 105(5):2074–2081. doi:10.1182/blood-2004-06-2282

    Article  PubMed  CAS  Google Scholar 

  131. Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y, Kanaoka Y, Conley P, Boyce JA (2009) Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 206(11):2543–2555. doi:10.1084/jem.20091240

    Article  PubMed  CAS  Google Scholar 

  132. Rauch BH, Rosenkranz AC, Ermler S, Bohm A, Driessen J, Fischer JW, Sugidachi A, Jakubowski JA, Schror K (2010) Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol 30(12):2434–2442. doi:10.1161/ATVBAHA.110.213702

    Article  PubMed  CAS  Google Scholar 

  133. Wang L, Jacobsen SE, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5:16. doi:10.1186/1471-2172-5-161471-2172-5-16

    Article  PubMed  CAS  Google Scholar 

  134. Jacobson KA, Boeynaems JM (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 15(13–14):570–578. doi:10.1016/j.drudis.2010.05.011

    Article  PubMed  CAS  Google Scholar 

  135. Semple JW, Italiano JE, Freedman J (2011) Platelets and the immune continuum. Nat Rev 11(4):264–274. doi:10.1038/nri2956

    Article  CAS  Google Scholar 

  136. Marteau F, Communi D, Boeynaems JM, Suarez Gonzalez N (2004) Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells. J Leukoc Biol 76(4):796–803

    Article  PubMed  CAS  Google Scholar 

  137. Sasaki Y, Hoshi M, Akazawa C, Nakamura Y, Tsuzuki H, Inoue K, Kohsaka S (2003) Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 44(3):242–250. doi:10.1002/glia.10293

    Article  PubMed  Google Scholar 

  138. De Simone R, Niturad CE, De Nuccio C, Ajmone-Cat MA, Visentin S, Minghetti L (2010) TGF-beta and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. J Neurochem 115(2):450–459. doi:10.1111/j.1471-4159.2010.06937.x

    Article  PubMed  CAS  Google Scholar 

  139. Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K (2008) P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 28(19):4949–4956. doi:10.1523/JNEUROSCI.0323-08.2008

    Article  PubMed  CAS  Google Scholar 

  140. Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K (2008) P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 28(11):2892–2902. doi:10.1523/JNEUROSCI.5589-07.2008

    Article  PubMed  CAS  Google Scholar 

  141. Amadio S, Tramini G, Martorana A, Viscomi MT, Sancesario G, Bernardi G, Volonte C (2006) Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. Neuroscience 141(3):1171–1180. doi:10.1016/j.neuroscience.2006.05.058

    Article  PubMed  CAS  Google Scholar 

  142. Amadio S, Montilli C, Magliozzi R, Bernardi G, Reynolds R, Volonte C (2010) P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb Cortex 20(6):1263–1273. doi:10.1093/cercor/bhp193

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I would like to thank Béatrice Hechler for her critical review of the manuscript.

Author information

Authors and Affiliations

  1. UMR_S949 Inserm, Université de Strasbourg, EFS-Alsace 10, rue Spielmann, BP N°36, 67065, Strasbourg, France

    Christian Gachet

Authors
  1. Christian Gachet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Gachet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gachet, C. P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signalling 8, 609–619 (2012). https://doi.org/10.1007/s11302-012-9303-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11302-012-9303-x

Keywords

Search

Navigation